Finerenone reduced the incidence of the primary composite endpoint of CV death, nonfatal MI, nonfatal stroke or hospitalization for heart failure by 13%. The prescribing information for Kerendia ® ...
The American Heart Association (AHA) has released an updated scientific statement to help guide clinicians treating children and adolescents who have a high risk for premature CVD. The document ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback